V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215820 | 20088718 | 1.81 | 89 | Palliative (P) | 2017-10-16 | 2017-11-11 | EOF | 02 | N | ABVD | 100278119 |
| 20215844 | 20088719 | 1.81 | 74.3 | Palliative (P) | 2018-12-04 | 2019-01-08 | MITOMYCIN | 02 | N | POMALIDOMIDE | 100420478 |
| 20215936 | 20088720 | 1.59 | 45 | Palliative (P) | 2018-08-20 | 2018-08-21 | POMALIDOMIDE | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101630201 |
| 20215999 | 20088721 | 1.78 | 72 | Palliative (P) | 2017-07-18 | 2017-07-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100504629 |
| 20216021 | 20088722 | 1.54 | 54.8 | Palliative (P) | 2017-09-25 | 2017-10-29 | null | 02 | N | CARBO + FLUOROURACIL | 101029238 |
| 20216145 | 20088723 | null | 61.5 | Palliative (P) | 2018-09-18 | 2018-09-18 | CARBOPLATIN + VINORELBINE | N | N | CARBOPLATIN + RALTITREXED | 100682178 |
| 20216203 | 20088724 | 1.64 | 105.3 | Palliative (P) | 2020-03-24 | 2020-04-21 | FCarboSt | Y | N | VENETOCLAX | 101603403 |
| 20216228 | 20088725 | 1.73 | 64.2 | Palliative (P) | 2017-02-11 | 2017-03-04 | RALTITREXED | 02 | N | AZACITIDINE | 100225055 |
| 20216245 | 20088726 | 1.59 | 118 | 03 | null | 2018-07-18 | Paclitaxel+Trastuzumab wkly Maint | null | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101232950 |
| 20216277 | 20088727 | 1.62 | 65 | Adjuvant (A) | 2017-09-27 | 2017-10-14 | CHOP R - 21 days | 02 | N | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 101139226 |
| 20216345 | 20088728 | 1.7 | 64.6 | Adjuvant (A) | 2017-04-19 | 2017-05-07 | Carboplatin + Pemetrexed | 02 | N | CARBO + FLUOROURACIL | 101473051 |
| 20216410 | 20088729 | 1.51 | 60.4 | Palliative (P) | 2017-04-27 | 2017-04-27 | Streptozocin + MdG | 01 | N | ALECTINIB | 101170759 |
| 20216432 | 20088730 | 0 | 0 | Palliative (P) | 2018-11-20 | 2018-11-26 | Cyclophosphamide + Docetaxel | 01 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101148368 |
| 20216468 | 20088731 | 1.6 | null | Palliative (P) | 2016-04-03 | 2016-04-04 | Irinotecan | 02 | null | CISPLATIN + FLUOROURACIL + RT | 101853436 |
| 20216497 | 20088732 | 1.61 | 48.85 | Palliative (P) | 2019-10-05 | 2019-10-05 | Carboplatin + Vinorelbine IV | 02 | N | ARISTOTLE TRIAL | 100298560 |
| 20216504 | 20088733 | 1.62 | 70 | Neo-adjuvant (N) | 2018-08-06 | 2018-08-22 | Docetaxel | 01 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100155579 |
| 20216542 | 20088734 | 1.68 | 105.2 | 03 | 2018-12-20 | 2018-12-31 | CHOP R | 02 | N | FCARBOST | 100867680 |
| 20216564 | 20088735 | 1.5 | 80.95 | Adjuvant (A) | 2018-08-19 | 2018-08-26 | Ralitrexed | 02 | N | STS NON-RHABDO EPSSG 2005 VDCY | 100380810 |
| 20216702 | 20088736 | 1.78 | 78.6 | 03 | null | 2019-06-30 | FLUOROURACIL + RT | Y | N | RITUXIMAB | 100102701 |
| 20216709 | 20088737 | 1.8 | 97 | Palliative (P) | null | 2018-09-15 | ACELARATE Trial | 01 | N | CETUXIMAB + IRINOTECAN | 100174133 |
| 20216723 | 20088738 | 1.6 | 60 | Palliative (P) | 2016-10-22 | 2016-10-22 | SCOPE 2 TRIAL | 02 | N | GEMCITABINE + PACLITAXEL | 100300263 |
| 20216833 | 20088740 | 1.69 | 76 | Palliative (P) | null | 2018-09-15 | Raltitrexed | 01 | Y | BENDAMUSTINE + RITUXIMAB | 101529017 |
| 20216940 | 20088742 | 1.6 | null | 03 | 2016-05-24 | 2016-05-26 | EP | 02 | N | GEMCITABINE + PACLITAXEL | 100238300 |
| 20217055 | 20088744 | 1.85 | 58.4 | 03 | 2017-11-25 | 2017-11-25 | CHOP R | 02 | N | SCOPE2 TRIAL | 101175464 |
| 20217138 | 20088746 | 1.65 | 50.95 | 03 | 2018-11-04 | 2018-11-10 | Irinotecan 14day | 02 | N | HYDROXYCARBAMIDE | 100026444 |
| 20217208 | 20088747 | 1.69 | 38.7 | 03 | 2017-05-02 | 2017-05-07 | SCOPE 2 TRIAL | 02 | N | GEMCARBO | 100203488 |
| 20217411 | 20088750 | null | 56 | null | null | 2017-12-17 | ARISTOTLE TRIAL | 01 | N | EVEROLIMUS | 101264157 |
| 20217473 | 20088751 | 1.57 | 66.4 | Palliative (P) | 2019-06-10 | 2019-07-06 | Raltitrexed | 02 | N | RITUXIMAB | 101055865 |
| 20217550 | 20088752 | 1.8 | 117 | Palliative (P) | 2019-07-04 | 2019-07-04 | CARBOPLATIN + FLUOROURACIL | N | N | BALLAD TRIAL | 101585541 |
| 20217603 | 20088753 | null | 46 | 03 | 2018-11-11 | 2018-11-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | LETROZOLE + PALBOCICLIB | 101362530 |
| 20217723 | 20088754 | null | 58.1 | null | 2019-01-23 | 2019-01-23 | CVP R | 02 | N | GEMCARBO | 100683398 |
| 20217738 | 20088755 | 1.54 | 49 | Palliative (P) | null | 2017-02-04 | Capecitabine + Carboplatin + RT | 02 | N | EVEROLIMUS | 101110137 |
| 20217946 | 20088757 | 1.58 | 54 | Adjuvant (A) | 2019-03-15 | 2019-03-16 | Gemcitabine + Paclitaxel | 02 | N | ACTICCA-1 TRIAL | 101780736 |
| 20218089 | 20088758 | null | 98 | 03 | 2019-07-22 | 2019-07-22 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | CARBO + FLUOROURACIL | 100872689 |
| 20218123 | 20088759 | 1.78 | 70.7 | 03 | 2019-12-23 | 2020-01-07 | FEC | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100937178 |
| 20218161 | 20088761 | 1.72 | 88 | Palliative (P) | 2018-12-02 | 2018-12-02 | Cisplatin +FU +Trastuzumab - Load | null | N | PANITUMUMAB | 100382991 |
| 20218537 | 20088763 | 1.53 | null | Palliative (P) | 2019-06-09 | 2019-06-17 | ACELARATE Trial | 02 | N | CISPLATIN + RT | 100656898 |
| 20218548 | 20088764 | 1.65 | 75 | 03 | 2019-12-23 | 2019-12-27 | PLATO Trials | 2 | N | PLATO TRIAL | 101591771 |
| 20218589 | 20088766 | 1.65 | 47.8 | Palliative (P) | 2021-06-26 | 2021-06-26 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | BACILLUS CALMETTE-GUERIN | 100302031 |
| 20218603 | 20088767 | 1.58 | 70.8 | 03 | 2018-03-18 | 2018-03-19 | ACELARATE Trial | 01 | N | OXALIPLATIN | 100081160 |
| 20218613 | 20088768 | 0 | 10.1 | Palliative (P) | 2019-11-06 | 2019-11-08 | Raltitrexed | N | Y | CISPLATIN + VINORELBINE | 101376021 |
| 20218725 | 20088769 | 1.55 | 72.4 | 03 | 2017-02-04 | 2017-02-09 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | Y | GEMCITABINE + PACLITAXEL | 101219169 |
| 20218747 | 20088770 | 1.75 | 53.6 | null | 2019-08-29 | 2019-09-15 | CHLORAMBUCIL + RITUXIMAB | N | N | VEMURAFENIB | 100372477 |
| 20219004 | 20088771 | 0 | 0 | Palliative (P) | 2015-11-21 | 2015-11-21 | CHOP R - 21 days | 02 | N | BORTEZOMIB | 100114504 |
| 20219102 | 20088773 | null | 84.9 | null | 2018-10-31 | 2018-11-04 | OXALIPLATIN | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100175680 |
| 20219210 | 20088775 | null | 17.7 | 03 | 2019-08-04 | 2019-09-05 | CAV | 02 | N | IBRUTINIB | 100046118 |
| 20219258 | 20088776 | 1.54 | 98 | Palliative (P) | 2019-12-18 | 2020-01-14 | MITOMYCIN | N | N | DOXORUBICIN + OLARATUMAB | 100018952 |
| 20219423 | 20088777 | 1.57 | 91.4 | null | 2019-03-04 | 2019-03-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | BORTEZOMIB | 100262703 |
| 20219714 | 20088779 | 1.6 | 71.9 | null | 2017-11-07 | 2017-11-07 | Bevacizumab + Capecitabine | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100321831 |
| 20219725 | 20088780 | 1.62 | 54 | Palliative (P) | 2018-07-23 | 2018-08-11 | PLATO Trials | N | N | PLATO TRIAL | 100434847 |